Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06299462	PTCy and ATG for MSD and MUD Transplants	recruiting	Phase 1 / Phase 2	50	Instituto Nacional de Cancer, BrazilOTHER_GOV	1	Feb 25, 2025	clinicaltrials
NCT04072458	A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies	active not recruiting	Phase 1	30	Bio-Path Holdings, Inc.INDUSTRY	1	Feb 24, 2025	clinicaltrials